Rickettsial Genesis to Sarcoidosis in Denmark
Sponsor: Bispebjerg Hospital
Listed as NCT00326534, this observational or N/A phase trial focuses on Rickettsia Infections and Sarcoidosis and remains completed. Sponsored by Bispebjerg Hospital, it has been updated 10 times since 2006, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Sep 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bispebjerg Hospital
- Civilingeniør Johs. E. Ormstrup og Hustru Grete Ormstrups Fond
- Statens Serum Institut
For direct contact, visit the study record on ClinicalTrials.gov .